When Grammy-nominated singer-songwriterAloe Blaccgot COVID despite being vaccinated and boosted, he tried to fund research for a better solution.Whathequicklyfoundout? Youcan’tjust write a check in biotech. Regulators require a commercialization plan, and philanthropydoesn’tmove science through clinical trials or get you a license on university IP. Now,he’sbootstrapping a cancer drug platform targeting pancreatic cancer, a disease that kills 90% of its patients, andintentionally waiting to raise from his network until peer-reviewed papers can makehiscase.
Watch as Aloe Blacc joins Rebecca Bellan on TechCrunch’sEquitypodcast to talk about what happens when a creator decides to build instead of just invest, how Aloe iswatching AI reshapeboth the biotech andmusicindustriesin real time,and his thoughtsonwhoactually wins.
Subscribe to Equity onYouTube,Apple Podcasts,Overcast,Spotifyand all the casts. Youalso canfollow Equity onXandThreads, at @EquityPod.